Sidney Kimmel Cancer Center logo
 


News & Events
About SKCC
Research
Faculty
Clinical Programs
How You Can Help
SKCC Foundation
Careers at SKCC
Contact Us
Search
Home

F. Javier Piedrafita's
PubMed References

Lopez-Hernandez FJ, et al.
Reduced concentrations of serum enhance the antiproliferative activity of retinoid-related molecules and accelerate the onset of apoptosis.
Biochem Pharmacol., 2003; 65:2021-2030.

Lopez-Hernandez FJ, et al.
Z-FA-fmk inhibits effector caspases but not initiator caspases 8 and 10, and demonstrates that novel anticancer retinoid-related molecules induce apoptosis via the intrinsic pathway.
Mol Cancer Therapeutics, 2003; 2:255-263.

Bayon Y, et al.
Inhibition of IkB kinase by a new class of retinoid-related anticancer agents that induce apoptosis.
Mol Cell Biol 2003; 23(3):1061-1074.

Ortiz, M.A, et al.
Retinoids in combination therapies for the treatment of cancer: Mechanisms and Perspectives.
Drug Resistance Updates 2002;5(3-4):162-175.

Ortiz, M.A, et al.
Retinoid-related Molecules Induce Cytochrome c Release and Apoptosis through Activation of c-Jun NH2-Terminal Kinase/p38 Mitogen-activated Protein Kinases.
Cancer Res 2001;61 8504-8512.

Fanjul AN, et al.
Apoptosis induction and potent antiestrogen receptor-negative breast cancer activity in vivo by a retinoid antagonist.
Cancer Res. 1998 Oct 15;58(20):4607-10.

Piedrafita FJ, et al.
Retinoid-induced apoptosis and Sp1 cleavage occur independently of transcription and require caspase activation.
Mol Cell Biol. 1997 Nov;17(11):6348-58.

Piedrafita FJ, et al.
An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element.
J Biol Chem. 1996 Jun 14;271(24):14412-20.

Ortiz MA, et al.
TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals.
Mol Endocrinol. 1995 Dec;9(12):1679-91.

Piedrafita FJ, et al.
Thyroid hormone receptor-beta mutants associated with generalized resistance to thyroid hormone show defects in their ligand-sensitive repression function.
Mol Endocrinol. 1995 Nov;9(11):1533-48.

Bouterfa HL, et al.
Regulation of H1(0) gene expression by nuclear receptors through an unusual response element: implications for regulation of cell proliferation.
DNA Cell Biol. 1995 Nov;14(11):909-19.

Piedrafita FJ, et al.
Thyroid hormone receptor homodimers can function as ligand-sensitive repressors.
Mol Endocrinol. 1995 May;9(5):563-78.

Perez RA, et al.
Kinetics of the reversible tight-binding inhibition of pig liver catechol-O-methyltransferase by [2-(3,4-dihydroxy-2- nitrophenyl)vinyl]phenyl ketone.
J Enzyme Inhib. 1994;8(2):123-31.

Salbert G, et al.
Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity.
Mol Endocrinol. 1993 Oct;7(10):1347-56.

Perez RA, et al.
Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols. Kinetics of the irreversible inhibition by 3-(3-hydroxy-4-methoxy-5-nitro benzylidene)-2,4-pentanedione.
Biochem Pharmacol. 1993 May 25;45(10):1973-81.

Hermann T, et al.
V-erbA requires auxiliary proteins for dominant negative activity.
Oncogene. 1993 Jan;8(1):55-65.

 

News & EventsAbout the CenterResearch FacultyClinical Programs
How You Can HelpSKCC FoundationCareers at SKCC Contact UsSearchHome